(Q52005428)

English

Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity

scientific article published on September 25, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/14512316

Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity (English)

reason for preferred rank

most precise value

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14512316

14 March 2024

human subject research project

0 references

lymphocyte activation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14512316

14 March 2024

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

author name string

Mie Nieda

1

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/14512316

Miki Okai

2

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/14512316

Andrea Tazbirkova

3

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/14512316

Henry Lin

4

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/14512316

Ayako Yamaura

5

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/14512316

Kazuki Ide

6

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/14512316

Rick Abraham

7

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/14512316

Takeo Juji

8

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/14512316

David J. Macfarlane

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14512316

14 March 2024

Andrew J. Nicol

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14512316

14 March 2024

language of work or name

0 references

publication date

25 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/14512316

full work available at URL

http://ashpublications.org/blood/article-pdf/103/2/383/1694512/zh800204000383.pdf

Portable Document Format

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/14512316

103

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/14512316

2

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/14512316

383-389

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/14512316

Activation of human Valpha24NKT cells by alpha-glycosylceramide in a CD1d-restricted and Valpha24TCR-mediated manner

1

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V alpha 24 J alpha Q T cell receptor alpha chains

2

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells

3

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

4

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution

5

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

TRAIL expression by activated human CD4(+)V alpha 24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukemia cells

8

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

In vitro anti-tumour activity of alpha-galactosylceramide-stimulated human invariant Valpha24+NKT cells against melanoma.

9

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells

10

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes

11

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

Sequential production of interferon-gamma by NK1.1+ T cells and natural killer cells is essential for the antimetastatic effect of alpha -galactosylceramide

12

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

Critical contribution of IFN-γ and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of α-galactosylceramide

13

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice

14

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells

15

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells

17

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.

19

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells

21

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

22

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

Human peripheral blood Valpha24+ Vbeta11+ NKT cells expand following administration of alpha-galactosylceramide-pulsed dendritic cells

23

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets

25

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes.

26

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria

28

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

Natural killer T cell activation inhibits hepatitis B virus replication in vivo.

29

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease

30

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

CD8(+)NKR-P1A (+)T cells preferentially accumulate in human liver

31

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide

32

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

The roles of intrahepatic Valpha14(+) NK1.1(+) T cells for liver injury induced by Salmonella infection in mice.

34

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

CD1d on myeloid dendritic cells stimulates cytokine secretion from and cytolytic activity of V alpha 24J alpha Q T cells: a feedback mechanism for immune regulation

35

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers

36

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion

37

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

Glycolipid Antigen Drives Rapid Expansion and Sustained Cytokine Production by NK T Cells

38

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

Preserved IFN-alpha production of circulating Valpha24 NKT cells in primary lung cancer patients

39

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

40

1 reference

10.1182/BLOOD-2003-04-1155

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1155

14 March 2024

Identifiers

10.1182/BLOOD-2003-04-1155

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/14512316

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/14512316

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52005428&oldid=2103806409"